| Training cohort | Validation cohorts | |
---|---|---|---|
TCGA (362) | NODE (159) | ICGC (231) | |
status (%) | |||
 alive | 233 (64.4) | 103 (64.8) | 188 (81.4) |
 dead | 129 (35.6) | 56 (35.2) | 43 (18.6) |
time (mean (SD)) | 2.22 | 2.66 (1.11) | 67.20 (10.12) |
age (mean (SD)) | 59.52 | 53.69 (10.90) | 2.22 (1.14) |
stage (%) | |||
 I&II | 254 (70.2) | 105 (66.0) | 141 (61.0) |
 III&IV | 84 (23.2) | 54 (34.0) | 90 (39.0) |
 NA | 24 (6.6) | - | - |
gender (%) | |||
 female | 118 (32.6) | 31 (19.5) | 61 (26.4) |
 male | 244 (67.4) | 128 (80.5) | 170 (73.6) |
T_stage (%) | |||
 T1&T2 | 271 (74.9) | - | - |
 T3&T4 | 88 (24.3) | - | - |
 NA | 3 (0.8) | - | - |
bmi (mean (SD)) | 26.14 (8.47) | - | - |
tumor_grade (%) | |||
 G1 | 55 (15.2) | - | - |
 G2 | 174 (48.1) | - | - |
 G3 | 116 (32.0) | - | - |
 G4 | 12 (3.3) | - | - |
 NA | 5 (1.4) | - | - |